FGA
TXG icon

Fortis Group Advisors’s 10x Genomics TXG Stock Holding History

Fortis Group Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Sell
15,527
-267
-2% -$7K 0.1% 175
2026
Q1 		$348K Sell
15,794
-67,124
-81% -$1.34M 0.06% 216
2025
Q4 		$1.67M Buy
82,918
+62,766
+311% +$948K 0.28% 92
2025
Q3 		$275K Buy
+20,152
New +$263K 0.05% 201

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fortis Group Advisors's TXG Position: Q2 2026 in Review

Fortis Group Advisors reduced its 10x Genomics (TXG) stake by 1.7% in Q2 2026, selling an estimated $7K and leaving 15,527 shares worth $595K. The position accounts for 0.1% of the portfolio, ranked #175.

Fortis Group Advisors first reported a position in TXG in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.67M in Q4 2025. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Fortis Group Advisors held 15,527 shares of 10x Genomics worth $595K as of Q2 2026.
  • Fortis Group Advisors sold 267 10x Genomics shares in Q2 2026, an estimated $7K.
  • 10x Genomics made up 0.1% of Fortis Group Advisors's portfolio in Q2 2026, its #175 holding.
  • Fortis Group Advisors first reported a position in 10x Genomics in Q3 2025 and has held it in 4 quarters since.
  • Fortis Group Advisors's 10x Genomics position peaked at $1.67M in Q4 2025.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.